Skip to content

The effect of Chelidonium majus and Hyoscyamus niger with Propolis on diabetic foot ulcers

The effect of topical cream of Chelidonium majus and Hyoscyamus niger with Propolis on diabetic foot ulcers

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200516047462N3
Enrollment
88
Registered
2021-11-23
Start date
2021-11-21
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic food ulcers. Ulcer of lower limb, not elsewhere classified

Interventions

Intervention 1: The intervention group is included 44 patients with diabetic foot ulcers. During three weeks, topical cream containing 0.5 grams of Chelidonium majus and 0.5 grams of Hyoscyamus niger

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients with diabetes who take insulin and have diabetic foot ulcers and are in the age range of 18 to 85 years. Clinical judgment of the specialist physician based on receiving the product The patient's ability and its personal desire to fill out of personal consent form to enter the study

Exclusion criteria

Exclusion criteria: Existence of any history of allergy to any herbal product Patients who need surgery for their wounds

Design outcomes

Primary

MeasureTime frame
Size and extent of wound. Timepoint: At the beginning of the study, 4 days after treatment and 7 days after treatment, 14 days after treatment, 21 days after treatment. Method of measurement: In millimeters.;The infiltration of inflammatory cells, neutrophils, monocytes, synthesis and maturation of collagen, fibroblasts and keratinocytes and induction of angiogenesis. Timepoint: 21 days after treatment. Method of measurement: Tissue sample.;Nuclear hypertrophy of endothelial cells, vacuoles, diabetic foot ulcer granulation and tissue fibrosis. Timepoint: Twenty one days after treatment. Method of measurement: Histology.;The duration of treatment, the speed of recovery, the rate of symptoms reduction and the duration of disease recurrence. Timepoint: Twenty one days after treatment. Method of measurement: Check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMorteza Kosari

Kashan University of Medical Sciences

kosarimorteza12@gmail.com+98 31 5554 2999

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026